Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1992-1-9
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0959-8049
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1180-1
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1659852-Adenocarcinoma, Mucinous,
pubmed-meshheading:1659852-Antigens, Tumor-Associated, Carbohydrate,
pubmed-meshheading:1659852-Antineoplastic Agents,
pubmed-meshheading:1659852-Female,
pubmed-meshheading:1659852-Humans,
pubmed-meshheading:1659852-Ovarian Neoplasms,
pubmed-meshheading:1659852-Trypsin Inhibitors
|
pubmed:year |
1991
|
pubmed:articleTitle |
Tumor associated trypsin inhibitor and CA-125 during treatment of mucinous ovarian cancer in 2 patients.
|
pubmed:publicationType |
Letter,
Case Reports
|